In an in vitro study, the efficacy of sulforaphane treatment in HCT116 colon cancer cells under hypoxic conditions was examined, and it was observed that sulforaphane treatment dose-dependently suppressed HIF-1-regulated gene expressions such as VEGF, HO-1, and GLUT1. This evidence concerns the gene HIF1A and malignant colon neoplasm.